Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

The Case for a Bariatric-Centered Approach to Chronic Kidney Disease Care.

Friedman AN.

Clin J Am Soc Nephrol. 2019 Jan 10. pii: CJN.12061018. doi: 10.2215/CJN.12061018. [Epub ahead of print] No abstract available.

PMID:
30630858
2.

Use of Intradialytic Parenteral Nutrition in Patients Undergoing Hemodialysis.

Sarav M, Friedman AN.

Nutr Clin Pract. 2018 Dec;33(6):767-771. doi: 10.1002/ncp.10190. Epub 2018 Sep 12. Review.

PMID:
30207411
3.

Effect of Bariatric Surgery on CKD Risk.

Friedman AN, Wahed AS, Wang J, Courcoulas AP, Dakin G, Hinojosa MW, Kimmel PL, Mitchell JE, Pomp A, Pories WJ, Purnell JQ, le Roux C, Spaniolas K, Steffen KJ, Thirlby R, Wolfe B.

J Am Soc Nephrol. 2018 Apr;29(4):1289-1300. doi: 10.1681/ASN.2017060707. Epub 2018 Jan 15.

PMID:
29335242
4.

Hypothesis: Potential Utility of Serum and Urine Uromodulin Measurement in Kidney Transplant Recipients?

Bostom AG, Steubl D, Friedman AN.

Transplant Direct. 2017 Oct 6;3(11):e219. doi: 10.1097/TXD.0000000000000737. eCollection 2017 Nov. Review.

5.

Personal Attitudes Toward Weight in Overweight and Obese US Hemodialysis Patients.

Saeed Z, Janda KM, Tucker BM, Dudley L, Cutter P, Friedman AN.

J Ren Nutr. 2017 Sep;27(5):340-345. doi: 10.1053/j.jrn.2017.03.004. Epub 2017 May 19.

6.

Diagnosis and Management of Type 2 Diabetic Kidney Disease.

Doshi SM, Friedman AN.

Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1366-1373. doi: 10.2215/CJN.11111016. Epub 2017 Mar 9. Review.

7.

Serum phospholipid fraction of polyunsaturated fatty acids is the preferred indicator for nutrition and health status in hemodialysis patients.

Watkins BA, Kim J, Tamez H, Wenger J, Thadhani R, Friedman AN.

J Nutr Biochem. 2016 Dec;38:18-24. doi: 10.1016/j.jnutbio.2016.07.021. Epub 2016 Aug 26.

8.

Association between plasma endocannabinoids and appetite in hemodialysis patients: A pilot study.

Friedman AN, Kim J, Kaiser S, Pedersen TL, Newman JW, Watkins BA.

Nutr Res. 2016 Jul;36(7):658-62. doi: 10.1016/j.nutres.2016.03.009. Epub 2016 Apr 1.

9.

Medical Ethics in Nephrology: A Jewish Perspective.

Friedman AN.

Rambam Maimonides Med J. 2016 Apr 19;7(2). doi: 10.5041/RMMJ.10241. Review.

10.

Novel application of complementary imaging techniques to examine in vivo glucose metabolism in the kidney.

Hato T, Friedman AN, Mang H, Plotkin Z, Dube S, Hutchins GD, Territo PR, McCarthy BP, Riley AA, Pichumani K, Malloy CR, Harris RA, Dagher PC, Sutton TA.

Am J Physiol Renal Physiol. 2016 Apr 15;310(8):F717-F725. doi: 10.1152/ajprenal.00535.2015. Epub 2016 Jan 13.

11.

Is Bariatric Surgery an Effective Treatment for Type II Diabetic Kidney Disease?

Friedman AN, Wolfe B.

Clin J Am Soc Nephrol. 2016 Mar 7;11(3):528-35. doi: 10.2215/CJN.07670715. Epub 2015 Oct 8. Review.

12.

Is routine multivitamin supplementation necessary in US chronic adult hemodialysis patients? A systematic review.

Tucker BM, Safadi S, Friedman AN.

J Ren Nutr. 2015 May;25(3):257-64. doi: 10.1053/j.jrn.2014.09.003. Epub 2014 Oct 29. Review.

13.

Influence of dietary protein on glomerular filtration before and after bariatric surgery: a cohort study.

Friedman AN, Quinney SK, Inman M, Mattar SG, Shihabi Z, Moe S.

Am J Kidney Dis. 2014 Apr;63(4):598-603. doi: 10.1053/j.ajkd.2013.11.012. Epub 2013 Dec 31.

14.

Predicting the glomerular filtration rate in bariatric surgery patients.

Friedman AN, Moe S, Fadel WF, Inman M, Mattar SG, Shihabi Z, Quinney SK.

Am J Nephrol. 2014;39(1):8-15. doi: 10.1159/000357231. Epub 2013 Dec 19.

15.

Very low calorie ketogenic weight reduction diet in patients with cirrhosis: a case series.

Temmerman JC, Friedman AN.

Nutr Diabetes. 2013 Nov 18;3:e95. doi: 10.1038/nutd.2013.36.

16.

Short-term changes after a weight reduction intervention in advanced diabetic nephropathy.

Friedman AN, Chambers M, Kamendulis LM, Temmerman J.

Clin J Am Soc Nephrol. 2013 Nov;8(11):1892-8. doi: 10.2215/CJN.04010413. Epub 2013 Aug 8.

17.

Fatty acids and other risk factors for sudden cardiac death in patients starting hemodialysis.

Friedman AN, Yu Z, Denski C, Tamez H, Wenger J, Thadhani R, Li Y, Watkins B.

Am J Nephrol. 2013;38(1):12-8. doi: 10.1159/000351764. Epub 2013 Jun 25.

18.

The coming fiscal crisis: nephrology in the line of fire.

Andersen MJ, Friedman AN.

Clin J Am Soc Nephrol. 2013 Jul;8(7):1252-7. doi: 10.2215/CJN.00790113. Epub 2013 May 23.

19.

Obesity in patients undergoing dialysis and kidney transplantation.

Friedman AN.

Adv Chronic Kidney Dis. 2013 Mar;20(2):128-34. doi: 10.1053/j.ackd.2012.10.009. Review.

PMID:
23439371
20.

Inverse relationship between long-chain n-3 fatty acids and risk of sudden cardiac death in patients starting hemodialysis.

Friedman AN, Yu Z, Tabbey R, Denski C, Tamez H, Wenger J, Thadhani R, Li Y, Watkins BA.

Kidney Int. 2013 Jun;83(6):1130-5. doi: 10.1038/ki.2013.4. Epub 2013 Feb 6.

21.

A more cautious stance on nutritional supplementation for hypoalbuminemia is justified.

Friedman AN, Fadem SZ.

Am J Kidney Dis. 2013 Feb;61(2):349. doi: 10.1053/j.ajkd.2012.09.021. No abstract available.

PMID:
23318014
22.

Low blood levels of long-chain n-3 polyunsaturated fatty acids in US hemodialysis patients: clinical implications.

Friedman AN, Yu Z, Tabbey R, Denski C, Tamez H, Wenger J, Thadhani R, Li Y, Watkins BA.

Am J Nephrol. 2012;36(5):451-8. doi: 10.1159/000343741. Epub 2012 Nov 2.

23.

Comparative effects of low-carbohydrate high-protein versus low-fat diets on the kidney.

Friedman AN, Ogden LG, Foster GD, Klein S, Stein R, Miller B, Hill JO, Brill C, Bailer B, Rosenbaum DR, Wyatt HR.

Clin J Am Soc Nephrol. 2012 Jul;7(7):1103-11. doi: 10.2215/CJN.11741111. Epub 2012 May 31.

24.

Making measures count.

Friedman AN, Fadem SZ.

Clin J Am Soc Nephrol. 2011 Jun;6(6):1507-11. doi: 10.2215/CJN.11461210. Epub 2011 May 19.

25.

The importance of considering metabolism when indexing the GFR.

Friedman AN.

Am J Kidney Dis. 2010 Dec;56(6):1218; author reply 1219. doi: 10.1053/j.ajkd.2010.08.025. No abstract available.

PMID:
21094916
26.

Life-threatening post-thrombectomy hypotension due to residual complications from a translumbar catheter.

Friedman AN, Butty SD.

NDT Plus. 2010 Oct;3(5):465-7. doi: 10.1093/ndtplus/sfq112. Epub 2010 Jun 22.

27.

Omega-3 fatty acid supplementation in advanced kidney disease.

Friedman AN.

Semin Dial. 2010 Jul-Aug;23(4):396-400. doi: 10.1111/j.1525-139X.2010.00748.x. Review.

PMID:
20701719
28.

Independent influence of dietary protein on markers of kidney function and disease in obesity.

Friedman AN, Yu Z, Juliar BE, Nguyen JT, Strother M, Quinney SK, Li L, Inman M, Gomez G, Shihabi Z, Moe S.

Kidney Int. 2010 Oct;78(7):693-7. doi: 10.1038/ki.2010.184. Epub 2010 Jul 21.

29.

Measuring the glomerular filtration rate in obese individuals without overt kidney disease.

Friedman AN, Strother M, Quinney SK, Hall S, Perkins SM, Brizendine EJ, Inman M, Gomez G, Shihabi Z, Moe S, Li L.

Nephron Clin Pract. 2010;116(3):c224-34. doi: 10.1159/000317203. Epub 2010 Jul 2.

30.

Reassessment of albumin as a nutritional marker in kidney disease.

Friedman AN, Fadem SZ.

J Am Soc Nephrol. 2010 Feb;21(2):223-30. doi: 10.1681/ASN.2009020213. Epub 2010 Jan 14. Review.

31.

Feasibility study of erythrocyte long-chain omega-3 polyunsaturated fatty acid content and mortality risk in hemodialysis patients.

Friedman AN, Saha C, Watkins BA.

J Ren Nutr. 2008 Nov;18(6):509-12. doi: 10.1053/j.jrn.2008.08.007.

32.

Value of urinary albumin-to-creatinine ratio as a predictor of type 2 diabetes in pre-diabetic individuals.

Friedman AN, Marrero D, Ma Y, Ackermann R, Narayan KM, Barrett-Connor E, Watson K, Knowler WC, Horton ES; Diabetes Prevention Program Research Group.

Diabetes Care. 2008 Dec;31(12):2344-8. doi: 10.2337/dc08-0148. Epub 2008 Sep 16. Erratum in: Diabetes Care. 2009 May;32(5):968.. Friedman, Allon [corrected to Friedman, Allon N].

33.

Challenges of treating a 466-kilogram man with acute kidney injury.

Friedman AN, Decker B, Seele L, Hellman RN.

Am J Kidney Dis. 2008 Jul;52(1):140-3. doi: 10.1053/j.ajkd.2008.02.357. Epub 2008 May 21.

34.

Acute rise of omega-3 polyunsaturated fatty acids during hemodialysis treatment.

Friedman AN, Siddiqui R, Watkins BA.

J Ren Nutr. 2008 May;18(3):301-3. doi: 10.1053/j.jrn.2007.11.002.

35.

A pilot study in hemodialysis of an electrophysiological tool to measure sudden cardiac death risk.

Friedman AN, Groh WJ, Das M.

Clin Nephrol. 2007 Sep;68(3):159-64.

PMID:
17915618
36.

Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.

Saifullah A, Watkins BA, Saha C, Li Y, Moe SM, Friedman AN.

Nephrol Dial Transplant. 2007 Dec;22(12):3561-7. Epub 2007 Jul 10.

PMID:
17623719
37.

New evidence for an old strategy to help delay the need for dialysis.

Friedman AN.

Am J Kidney Dis. 2007 May;49(5):563-5. No abstract available.

PMID:
17472836
38.

Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis.

Friedman AN, Moe SM, Perkins SM, Li Y, Watkins BA.

Am J Kidney Dis. 2006 Jun;47(6):1064-71.

PMID:
16731302
39.

Adiposity in dialysis: good or bad?

Friedman AN.

Semin Dial. 2006 Mar-Apr;19(2):136-40. Review.

PMID:
16551291
40.

Total plasma homocysteine and arteriosclerotic outcomes in type 2 diabetes with nephropathy.

Friedman AN, Hunsicker LG, Selhub J, Bostom AG; Collaborative Study Group.

J Am Soc Nephrol. 2005 Nov;16(11):3397-402. Epub 2005 Sep 14.

41.

C-reactive protein as a predictor of total arteriosclerotic outcomes in type 2 diabetic nephropathy.

Friedman AN, Hunsicker LG, Selhub J, Bostom AG; Collaborative Study Group.

Kidney Int. 2005 Aug;68(2):773-8.

42.

High-protein diets: potential effects on the kidney in renal health and disease.

Friedman AN.

Am J Kidney Dis. 2004 Dec;44(6):950-62. Review.

PMID:
15558517
43.

Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy.

Friedman AN, Hunsicker LG, Selhub J, Bostom AG.

Atherosclerosis. 2004 Jan;172(1):121-5.

PMID:
14709365
44.

Regression of microalbuminuria in type 1 diabetes.

Friedman AN.

N Engl J Med. 2003 Aug 28;349(9):906-8; author reply 906-8. No abstract available.

PMID:
12944578
45.

Demographics and trends in overweight and obesity in patients at time of kidney transplantation.

Friedman AN, Miskulin DC, Rosenberg IH, Levey AS.

Am J Kidney Dis. 2003 Feb;41(2):480-7.

PMID:
12552513
46.

The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: a randomized, controlled study.

Friedman AN, Bostom AG, Laliberty P, Selhub J, Shemin D.

Am J Kidney Dis. 2003 Feb;41(2):442-6.

PMID:
12552508
47.

Bridges to Iran.

Friedman AN.

Lancet. 2002 Nov 23;360(9346):1694. No abstract available.

PMID:
12457815
48.

Overweight and obesity as a nutritional issue in the dialysis population.

Friedman AN, Mayer J.

Nephrol Dial Transplant. 2002 Dec;17(12):2273; author reply 2273-4. No abstract available.

PMID:
12454251
49.

Renovascular hypertension, endothelial function, and oxidative stress.

Friedman AN.

N Engl J Med. 2002 Nov 7;347(19):1528-30; author reply 1528-30. No abstract available.

PMID:
12421899
50.

Proteinuria as a predictor of total plasma homocysteine levels in type 2 diabetic nephropathy.

Friedman AN, Hunsicker LG, Selhub J, Bostom AG; Collaborative Study Group.

Diabetes Care. 2002 Nov;25(11):2037-41.

PMID:
12401753

Supplemental Content

Loading ...
Support Center